ロード中...
Can immunotherapy specifically target acute myeloid leukemic stem cells?
Accumulating evidence supports the role of leukemic stem cells (LSCs) in the high relapse rate of acute myeloid leukemia (AML) patients. The clinical relevance of LSCs, which were originally characterized in xenograft models, has recently been confirmed by the finding that stem cell-like gene expres...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601163/ https://ncbi.nlm.nih.gov/pubmed/23526057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22943 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|